Sudarshan Pharma Industries Ltd IPO
Sudarshan Pharma Industries Ltd is a BSE SME IPO listed on the BSE SME platform, priced at ₹71–₹73 per share. The stock debuted at ₹73 with a flat listing performance. The IPO had a lot size of ₹1600 shares and a minimum investment of ₹1,16,800.
Sudarshan Pharma Industries Ltd IPO
- IPO Dates
- Mar 9, 2023 – Mar 14, 2023
- Price band
- ₹71-73 per equity share
- Minimum Investment
- ₹1,16,800
- Issue size
- Fresh Issue : 6,862,400 shares of ₹10(aggregating up to ₹50.10 Cr)
- Lot size
- 1600
- Allotment Date
- Mar 17, 2023
- Listing
- Mar 22, 2023
- Listing At
- BSE SME
IPO timeline
-
Mar 9, 2023
Open Date
Completed
-
Mar 14, 2023
Close Date
Completed
-
Mar 17, 2023
Allotment Date
Completed
-
Mar 22, 2023
Listing Date
Completed
Sudarshan Pharma Industries Ltd IPO Essentials
Sudarshan Pharma Industries Ltd IPO Details
Sudarshan Pharma Industries Ltd IPO is priced at ₹71-73 per share with a total issue size of Fresh Issue : 6,862,400 shares of ₹10(aggregating up to ₹50.10 Cr). The IPO has a lot size of 1600 shares and is listed on BSE SME.
- Issue price
- ₹71-73 per equity share
- Lot size
- 1600 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- Fresh Issue : 6,862,400 shares of ₹10(aggregating up to ₹50.10 Cr)
- Listing at
- BSE SME
- List price
- 73.0
- Listing date
- Registrar
- KFin Technologies Limited
- Lead manager
-
Gretex Corporate Services Pvt Ltd
Sudarshan Pharma Industries Ltd IPO Analytics
Sudarshan Pharma Industries Ltd IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Sudarshan Pharma Industries Ltd IPO Subscription Status
Sudarshan Pharma Industries Ltd IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 521,600 / 1,908,800 | 3,651,200 | 6,081,600 |
|
Day 1
09-03-23 06:00 PM
|
(0.00 / 0.37) x | 0.46 x | 0.40 x |
|
Day 2
10-03-23 06:00 PM
|
(0.00 / 0.38) x | 0.67 x | 0.52 x |
|
Day 3
13-03-23 06:00 PM
|
(0.00 / 0.58) x | 0.88 x | 0.71 x |
|
Day 4
14-03-23 06:00 PM
|
(1.01 / 0.81) x | 1.20 x | 1.06 x |
Sudarshan Pharma Industries Ltd Valuations
Earnings
- EPS (Post IPO)
- ₹3.39/-
Returns
- RoNW
- 17.63%
Sudarshan Pharma Industries Ltd Financials( In Lakhs)
| 30-Jun-22 | 31-Mar-22 | 31-Mar-21 | 31-Mar-20 | |
|---|---|---|---|---|
| Assets | 14,703.74 | 13,752.18 | 9,926.02 | N/A |
| Revenue | 10,587.79 | 35,755.89 | 19,372.82 | N/A |
| Profit After Tax | 225.37 | 530.37 | 267.12 | N/A |
Sudarshan Pharma Industries Ltd Company & Offer Insights
About Sudarshan Pharma Industries Ltd
Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients' specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad.
The generic products supplied by the company have a wide application in paint, food, pharma, and adhesive industry. The company is involved in a contract manufacturing facility, supply and outsource of medicines and pharma formulation to hospitals, NGO, government and healthcare institutes. SPIL has 50 pharma formulations which are supplied under the brand name in the form of tablets, ointment, capsules, and injectable.
The company has its own sales force and distribution network in 5 states for ethical marketing of pharmaceutical formulation & products under the brand name in Indian and international markets. It also offers formulation development and QC services and provides customised solutions.
Sudarshan Pharma Industries Ltd Promoter(s)
Mr. Hemal Vasantrai Mehta, Mr. Sachin Vasantrai Mehta are the company's promoters of Sudarshan Pharma Industries Ltd.
Sudarshan Pharma Industries Ltd IPO Issue Objectives
- •
- Working Capital Requirements
- •
- General Corporate Purposes.
Contact Information
Frequently Asked Questions
Click any question to reveal the answer
Sudarshan Pharma Industries Ltd IPO is a book-built IPO worth ₹Fresh Issue : 6,862,400 shares of ₹10(aggregating up to ₹50.10 Cr). The price band is ₹71–₹73 per share. The IPO opens on Mar 9, 2023 and closes on Mar 14, 2023. It will be listed on BSE SME Platform. KFin Technologies Limited is the registrar.
The price band of Sudarshan Pharma Industries Ltd IPO is ₹71 to ₹73 per share.
The lot size of Sudarshan Pharma Industries Ltd IPO is 1600 shares.
The minimum investment for Sudarshan Pharma Industries Ltd IPO is approximately ₹1,16,800 based on the upper price band .
Sudarshan Pharma Industries Ltd IPO opens on Mar 9, 2023 and closes on Mar 14, 2023.
The allotment date of Sudarshan Pharma Industries Ltd IPO is Mar 17, 2023.
Sudarshan Pharma Industries Ltd IPO is expected to be listed on Mar 22, 2023, on BSE SME Platform.
Sudarshan Pharma Industries Ltd IPO valuation snapshot: P/E N/A, EPS ₹3.39/-, P/B N/A, RoNW 17.63%, and market cap N/A.
To apply for Sudarshan Pharma Industries Ltd IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Sudarshan Pharma Industries Ltd IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Sudarshan Pharma Industries Ltd IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Sudarshan Pharma Industries Ltd IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Sudarshan Pharma Industries Ltd IPO allotment status on IPO Ji for quick and easy access.